Ravi Deshpande joins ELNA Medical as Chief Business Development Officer, Canada
Deshpande will facilitate our ambitious projects for Canada and the US
ELNA Medical has appointed Ravi Deshpande as Chief Business Development Officer, Canada. Deshpande has held a range of management positions at McKesson for over 15 years. Among others, he was Chief Strategy Officer for McKesson Canada and Senior Vice-President at Medicentres; he played a key role in the expansion of the multinational’s Canadian footprint, tripling the pharmacy network through numerous acquisitions.
A registered pharmacist, Deshpande has held appointments in the hospital sector in Toronto and the US and served as Assistant Professor of Medicine in North Carolina. He co-founded Phase 4 Health, a pharmaceutical services firm providing patient, prescription, and consultant services to the pharmaceutical industry, acquired by McKesson Canada in 2005.
“I am pleased to welcome Deshpande to our management team, stated Laurent Amram, President and Founder, ELNA Medical. Deshpande is an accomplished executive who brings a wealth of impressive experience from a global Fortune 500 organisation that is a leader in the pharmaceutical distribution industry and healthcare solutions. He will facilitate our ambitious projects for Canada and the US.”
